FDA granted designation for a drug under Gibbs' leadership, involving GSK and Gilead Sciences.

The entities involved

• GSK →

  British multinational pharmaceutical and biotechnology company

  • Clement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Mon 15:26
  • GSK acquired Sierra Oncology.Mon 14:28
• Gilead Sciences →

  American company

  • Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.Sun 22:40
  • A pilot program is underway involving the federal government, Benue State, and Gilead Sciences, with the state participating in the drug supply management.Sat 01:51
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• GSK and EXEL are developing treatments for PBC, and the FDA granted accelerated approval to Gilead Sciences for related therapies.Jun 8
• GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16
• Collaboration revenue from GSK increased total revenue, and FDA action is needed for tepipenem HBR approval.Jun 7
• GSK gained FDA clearance for a lung cancer medicine, while the FDA began reviewing other highly anticipated drugs.Aug 4